The pharmaceutical industry is currently undergoing a massive shift toward smart manufacturing. Recently, Rockwell Automation and Adasoft reached a major milestone by digitalizing batch execution for Laboratorios Farmacéuticos Rovi. This collaboration highlights how industrial automation and control systems are replacing outdated paper-based methods. Consequently, Rovi has improved its operational efficiency and strengthened its data integrity across its manufacturing sites.

Transitioning from Paper to Digital Batch Execution

Rovi aimed to eliminate manual record-keeping to reduce human error. To achieve this, the team deployed the FactoryTalk PharmaSuite® Manufacturing Execution System (MES). This software acts as a bridge between the plant floor and high-level business platforms. Moreover, the system integrates seamlessly with Enterprise Resource Planning (ERP) and Laboratory Information Management Systems (LIMS). This connectivity ensures that data flows in real-time, which is essential for modern factory automation.

Achieving Rapid Results Through Strategic Integration

The first phase of the project concluded in less than one year. As a result, Rovi reported significantly shorter review times and improved product traceability. By using a standardized approach, the company created a blueprint for its future facilities. This “copy-paste” model for DCS (Distributed Control Systems) and MES deployment minimizes risks during scaling. Furthermore, it allows the company to maintain high competitiveness in the global contract manufacturing market.

The Critical Role of Certified System Integrators

Adasoft, a Gold-level partner in the Rockwell Automation ecosystem, provided the necessary technical expertise. In highly regulated environments like pharmaceuticals, integration is often more challenging than the software itself. Adasoft ensured that the new digital tools aligned with existing PLC (Programmable Logic Controller) frameworks. Their deep understanding of GxP standards helped Rovi maintain strict compliance throughout the transition.

Author Perspective: Why Digital Maturity is Non-Negotiable

From an industry standpoint, Rovi’s success proves that digitalization is no longer optional for pharma leaders. While many firms hesitate due to validation complexities, this project shows that a phased approach works. I believe the integration of MES with LIMS is the “secret sauce” for Quality by Design. It allows for proactive adjustments rather than reactive corrections. Therefore, companies that delay these upgrades will likely face higher compliance costs and lower yield rates in the coming years.